Participants from the Ministry of Ayush, the National Medicinal Plant Board and the World Health Organisation said inconsistent plant quality and opaque sourcing continue to constrain the sector’s domestic scale-up and export prospects. With India’s Ayush industry valued at over USD 50 billion and expanding at 17 per cent annually, speakers said farm-level quality validation using technology is increasingly seen as a prerequisite for sustaining growth and building international confidence, rather than a future upgrade.
The Export Imperative And The Quality Bottleneck
India’s medicinal plant sector is at a crossroads of soaring demand and stringent global scrutiny. Exports of Ayush and herbal products grew to Rs 5,907 crore (approximately USD 690 million) in the 2025 financial year, according to data from the Ministry of Commerce and Industry cited by the India Brand Equity Foundation (IBEF). This growth is fuelled by rising international enquiries for extracts of plants like ashwagandha, turmeric, and shatavari, as reported from manufacturing hubs like Indore.
However, this export momentum is checked by recurring compliance risks. Global regulators in the European Union and the United States, along with the WHO, increasingly demand documented proof of a product’s journey from seed to shelf. “Indian herbal exports face frequent quality queries related to adulteration, species misidentification, heavy metals (and) pesticide residues,” notes industry analysis. Without verifiable, digitised records starting at the point of harvest, Indian manufacturers and exporters face rejection, costly reprocessing, and brand damage.
Blockchain: Building Irrefutable Trust For Global Markets
While AI addresses quality assessment, blockchain technology is seen as the backbone for the traceability demanded by premium international markets. The seminar dedicated a full brainstorming session to blockchain’s role in ensuring supply-chain transparency. A blockchain-based ledger creates an immutable record of every transaction—from the farmer’s plot, through processing, to the export container—making the supply chain auditable and fraud-resistant.
This is rapidly transitioning from a value-add to a commercial necessity. The Global Ag Tech Initiative reports that the blockchain in the agriculture and food supply chain market will garner a 36 per cent CAGR from 2024 to 2032, driven by consumer demand for provenance. For Indian medicinal plants, this is particularly relevant for compliance with frameworks like the EU Pharmacopoeia, which was a key focus of the upcoming AVF Asia Forum 2026 in Bangalore, as per HortiDaily.
Dharmendra Rai, country director of the Association for Vertical Farming (AVF) India, emphasised, “Medicinal plants are not just crops… Quality, consistency, traceability, and compliance are essential if these plants are going into pharmaceuticals, nutraceuticals, or export markets.” Blockchain is the technological answer to this imperative, transforming traceability into a tangible asset that can command higher prices and ensure market access.
Aligning Farmer Incentives With Industry Needs
A critical insight from the seminar was that technology must benefit the primary producer to be effective. Inconsistent quality currently hurts farmer incomes as much as it hurts manufacturer margins. AI-enabled fair grading at the farm gate can ensure farmers receive appropriate prices for superior quality, creating a direct incentive to adopt better cultivation and post-harvest practices.
International Plant Scientist Awards:
Website: plantscientist.org
Nomination Link
Registration Link
Here with connected:
Follow the Plant Scientist Awards channel on WhatsApp:
Blog
Instagram
Pinterest
YouTube
Twiter
Comments
Post a Comment